Embecta Corp. (EMBC): Operating Cash Flow

Annual figures by period end, from SEC filings.

$191.70M
Year ended 2025-09-30
$174.10M
Trailing 12 months to 2026-06-30
-22.5%
3-year compound annual growth
-17.4%
5-year compound annual growth
$498.50M2020-09-30: $498.50M2021-09-30: $456.30M2022-09-30: $412.20M2023-09-30: $67.70M2024-09-30: $35.70M2025-09-30: $191.70M$191.70M
2020-09-30 Operating Cash Flow (USD) 2025-09-30
Period endedOperating Cash FlowChange YoYSource filing
2025-09-30$191.70M+437.0%2025-11-25, From 2024-10-01
2024-09-30$35.70M-47.3%2025-11-25, From 2023-10-01
2023-09-30$67.70M-83.6%2025-11-25, From 2022-10-01
2022-09-30$412.20M-9.7%2024-12-11, From 2021-10-01
2021-09-30$456.30M-8.5%2023-11-29, From 2020-10-01
2020-09-30$498.50Mn/a2022-12-22, From 2019-10-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Embecta Corp. (EMBC)2025-09-30$191.70M+437.0%
Tandem Diabetes Care Inc (TNDM)2025-12-31-$9.72Mn/m
Inspire Medical Systems, Inc. (INSP)2025-12-31$116.98M-10.2%
Haemonetics Corp (HAE)2026-03-28$293.22M+61.4%
Penumbra Inc (PEN)2025-12-31$238.66M+41.7%
Orthofix Medical Inc. (OFIX)2025-12-31$33.35M+29.3%
Merit Medical Systems Inc (MMSI)2025-12-31$297.37M+34.7%
Alphatec Holdings, Inc. (ATEC)2025-12-31$45.23Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31$80.86Mn/m

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗